US Patent Issued to Mirati Therapeutics on Jan. 20 for "Compositions of adagrasib and mTOR inhibitors and methods of treatment therewith" (California Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,795, issued on Jan. 20, was assigned to Mirati Therapeutics Inc. (Princeton, N.J.).

"Compositions of adagrasib and mTOR inhibitors and methods of treatment therewith" was invented by Peter Olson (San Diego), Ruth Wei Aranda (San Diego), James Gail Christensen (San Diego), Lars Daniel Engstrom (Carlsbad, Calif.) and Jill Hallin (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to combination therapies for treating KRas G12C cancers. In particular, the present invention relates to methods of treating cancer in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ...